Experts throughout Europe have contributed to this European Heart Journal supplement with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.
Mir B Basir, DO, discusses the impact of the DanGer Shock RCT in clinical practice, and looks into the future of AMI cardiogenic shock treatment and management.
This paper discusses the latest guidance for identifying patients with cardiogenic shock (CS) who are candidates for mechanical circulatory support (MCS).
In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.
This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.
Jaime Hernandez, MD, and Bobbi Bogaev Chapman, MD, discuss the clinical presentation and in-hospital trajectory of heart failure and cardiogenic shock from Dr. Hernandez's most recent publication with the Shock Working Group.
Alan Gass, M.D., FACC from Westchester Medical Center presents a case of a 48-year-old male without prior medical history who presented to a local hospital with several hours of chest pain.
Vasileios Panoulas, MD, discusses data regarding completeness of revascularization in high-risk PCI with mechanical circulatory support (MCS) at EuroPCR 2023.
Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”
